Innovation in response to the COVID-19 pandemic set a new historical precedent. COVID vaccines were brought to market in just 9 months, including vaccines using platforms that had never been commercialized. Previously, the record for bringing a novel vaccine to society was 4 years.
IP protection facilitated innovation to fight the pandemic. It contributed to the development of the background technology and know-how that was quickly leveraged for the COVID-19 response. It facilitated investments to bring new COVID treatments to market. It enabled collaboration, which accelerated innovation. And it supported massive knowledge transfer, as global manufacturing networks were rapidly established to produce billions of doses.
Below we present a selection of articles about COVID-related innovation and the enabling role of IP in the pandemic response.